Drug
MK-2828
MK-2828 is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
active_not_recruiting125%
recruiting375%
Recent Activity
4 active trials
Showing 4 of 4
active_not_recruitingphase_1
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
NCT07089784
recruitingphase_1
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
NCT07348237
recruitingphase_1
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
NCT07431866
recruitingphase_1
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
NCT07435194
Clinical Trials (4)
Showing 4 of 4 trials
NCT07089784Phase 1
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
NCT07348237Phase 1
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
NCT07431866Phase 1
A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
NCT07435194Phase 1
A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4